LOGO
LOGO

Quick Facts

SSR Mining Projects 10% Increase In FY25 Gold Production

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

SSR Mining Inc. (SSRM) Monday announced a 10 percent increase in full-year 2025 gold equivalent production guidance.

The Company projects to deliver production of 410,000 to 480,000 gold equivalent ounces from its Marigold, CC&V, Seabee and Puna operations. The consolidated cost of sales is expected at $1,375 to $1,435 per payable ounce and All-in sustaining costs or AISC of $2,090 to $2,150 per payable ounce. The company said exclusive of Care & Maintenance costs at ??pler, it expects full-year consolidated AISC to be $1,890 to $1,950 per payable ounce.

SSR Mining's CC&V acquisition was completed on February 28, 2025. CC&V's attributable production and cost guidance reflect the period of March 1, 2025 to December 31, 2025.

The company said discussions with Turkish government authorities are ongoing regarding mine restart and remediation and containment costs are estimated at $50 to $90 million in 2025.

Rod Antal, Executive Chairman of SSR Mining, said, "Our Americas assets, recently bolstered by the acquisition
of CC&V, are well positioned for significant production growth and strong cash flows in 2025. In addition, we see attractive and low capital intensity opportunities to potentially extend the mine lives at each of these assets going forward and will continue to progress technical work through the year."

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update -May 18 – May 22, 2026

May 22, 2026 14:46 ET
Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.

Latest Updates on COVID-19